Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat

Neurology

Volumn 48, Issue 4, 1997, Pages 921-926

  Rosenberg, Gary A ^a,b   Navratil, Milo ^b  

^a VA Medical Center   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BB 1101; METALLOPROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN WATER; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

EID: 0030899195     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.48.4.921     Document Type: Article

References (30)

1. Katzman R, Clasen R, Klatzo I, Meyer JS, Pappius HM, Waltz AG. Report of Joint Committee for Stroke Resources. IV. Brain edema in stroke. Stroke 1977;8:512-540.
2. Caplan LR. Intracerebral haemorrhage. Lancet 1992;339:656-658.
3. Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M. Collagenase-induced intracerebral hemorrhage in rats. Stroke 1990;21:801-807.
4. Rosenberg GA, Dencoff JE, McGuire PG, Liotta LA, Stetler- Stevenson WG. Injury-induced 92-kDa gelatinase and urokinase expression in rat brain. Lab Invest 1994;71:417-422.
5. Rosenberg GA, Kornfeld M, Estrada E, Kelley RO, Liotta LA, Stetler-Stevenson WG. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res 1992; 576:203-207.
6. Davies B, Brown PD, East N, Crimmin MJ, Balkwill FR. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 1993;53:2087-2091.
7. Brown MS, Kornfeld M, Mun-Bryce S, Sibbitt RR, Rosenberg GA. Comparison of magnetic resonance imaging and histology in collagenase-induced hemorrhage in the rat [see comments]. J Neuroimaging 1995;5:23-33.
8. Kase CS, Pessin MS, Zivin JA, et al. Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator. Am J Med 1992;92:384-390.
9. Anonymous. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333: 1581-1587.
10. Gearing AJ, Beckett P, Christodoulou M, et al. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 1994;370:555-557.
11. Rosenberg GA, Estrada EY, Dencoff JE, Stetler-Stevenson WG. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res 1995;703:151-155.
12. Rosenberg GA, Estrada E, Wesley M, Kyner WT. Autoradiographic patterns of brain interstitial fluid flow after collagenase-induced hemorrhage in rat. Acta Neurochir 1990; 51:280-282.
13. Tuhrim S, Dambrosia JM, Price TR, et al. Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival [see comments]. Ann Neurol 1991; 29:658-663.
14. Nagase H, Barrett AJ, Woessner JF. Nomenclature and glossary of the matrix metalloproteinases. In: Birkedal-Hansen H, Werb Z, Welgus HG, Van Wart HE, eds. Matrix metalloproteinases and inhibitors. Stuttgart: Gustav Fischer, 1992:421-424.
15. Rosenberg GA. Matrix metalloproteinases in brain injury. J Neurotrauma 1995;12:833-842.
16. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980;284:67-68.
17. Herron GS, Werb Z, Dwyer K, Banda MJ. Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J Biol Chem 1986;261:2810-2813.
18. Apodaca G, Rutka JT, Bouhana K, et al. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 1990;50:2322-2329.
19. Colton CA, Keri JE, Chen WT, Monsky WL. Protease production by cultured microglia: substrate gel analysis and immobilized matrix degradation. J Neurosci Res 1993;35:297-304.
20. Gottschall PE, Yu X. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem 1995;64:1513-1520.
21. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-376.
22. Reich R, Thompson EW, Iwamoto Y, et al. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 1988;48:3307-3312.
23. Cammer W, Bloom BR, Norton WT, Gordon S. Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc Natl Acad Sci USA 1978;75:1554-1558.
24. Sinar EJ, Mendelow AD, Graham DI, Teasdale GM. Experimental intracerebral haemorrhage: the effect of nimodipine pretreatment. J Neurol Neurosurg Psychiatry 1988;51:651-662.
25. Elger B, Seega J, Brendel R. Magnetic resonance imaging study on the effect of levemopamil on the size of intracerebral hemorrhage in rats. Stroke 1994;25:1836-1841.
26. Rosenberg GA, Navratil MJ. (S)-emopamil reduces brain edema from collagenase-induced hemorrhage in rats. Stroke 1994;25:2067-2071.
27. Rosenberg GA, Scremin O, Estrada E, Kyner WT. Arginine vasopressin V1-antagonist and atrial natriuretic peptide reduce hemorrhagic brain edema in rats. Stroke 1992;23:1767-1773.
28. McKissock W, Richardson A, Taylor J. Primary intracerebral haemorrhage: a controlled trial of surgical and conservative treatment in 180 unselected cases. Lancet 1961;2:221-226.
29. Batjer HH, Reisch JS, Allen BC, Plaizier L-J, Su CJ. Failure of surgery to improve outcome in hypertensive putaminal hemorrhage. A prospective randomized trial. Arch Neurol 1990;47: 1103-1106.
30. Grotta JC. Current medical and surgical therapy for cerebrovascular disease. N Engl J Med 1987;317:1505-1516.